BOC Sciences Continues to Enlarge Its Publication Collection Using BOC Sciences Products
News Nov 15, 2017
To date, there are 122 published articles altogether in this collection. This large collection is an earned honor for BOC Sciences after the past fifteen years of endeavors and fully demonstrates that products offered by BOC Sciences have received enough recognition among scholars and researchers, contributing to the advance of scientific explorations.
Published in Scientific Reports, ACS Applied Materials & Interfaces, Cells as well as dozens of other world-renowned professional scientific magazines and journals, many valuable findings are made concerning a wide range of research topics such as chemical synthesis, discovery of new and novel drugs to treat cancers, high blood pressure, heart disease, etc.
For example, celastrol purchased from BOC Sciences (Shirley, NY) was used as supplemental experimental procedures reagents in the research of obesity treatment. The relevant findings was compiled in an article titled Treatment of Obesity with Celastrol, which was published in Cell.
Founded in 2005 as a company specializing in small-molecule inhibitors, BOC Sciences has now expanded to offer a comprehensive range of chemical products and related solutions in the pharmaceutical industry including bioconjugation, biochemistry, biochemical and cellular analysis, compound synthesis and other clinical studies. “This means that customers now can find nearly whatever they want or need from BOC Sciences, which is the goal we are always striving for,” stated the Manager of Public Relations at BOC Sciences.
As always, BOC Sciences will continue to offer premium chemicals and meanwhile assist its customers with a complete suite of CRO services spanning the entire molecule development.
Cancer Comes Back All 'Jacked Up' on Stem CellsNews
Recent work increasingly shows that tumors are not static - the populations of cells that make up a tumor evolve over time in response to treatment, often in ways that lead to treatment immunity. Instead of being defined by a snapshot, tumors are more like a movie. This means that a tumor that recurs after treatment may be much different than the tumor originally seen in a biopsy.READ MORE
Small Tweak Makes Progress Towards Improved Flu TreatmentNews
Researchers report that a tweak to a small-molecule drug shows promise for future production of new antiviral therapies that could help patients, regardless of the strain with which they are infected.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018